01 6Yescarta
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 563
2019 Revenue in Millions : 456
Growth (%) : 23
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 695
2020 Revenue in Millions : 563
Growth (%) : 23
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 1,160
2021 Revenue in Millions : 695
Growth (%) : 67
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 1,498
2022 Revenue in Millions : 1,160
Growth (%) : 29
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 264
2017 Revenue in Millions : 7
Growth (%) : 3671%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 456
2018 Revenue in Millions : 264
Growth (%) : 73
LOOKING FOR A SUPPLIER?
